tradingkey.logo

Royalty Pharma Acquires Remaining Royalty Interest In Roche’S Evrysdi For $240 Million

ReutersDec 29, 2025 10:47 PM

- Royalty Pharma PLC RPRX.O:

  • ROYALTY PHARMA ACQUIRES REMAINING ROYALTY INTEREST IN ROCHE’S EVRYSDI FOR $240 MILLION AND POTENTIAL MILESTONES

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Related Articles

Tradingkey
KeyAI